Video

Mitzi Wasik Explains the Unfolding Landscape of Pay-for-Performance Models

As a part of the changing value-based payment model landscape, pay-for-performance programs for medication adherence measures are new for physicians and providers need help understanding the program, explained Mitzi Wasik, PharmD, BCPS.

director of Pharmacy Medicare Programs at Aetna.

PharmD, BCPS,

As a part of the changing value-based payment model landscape, pay-for-performance (P4P) programs for medication adherence measures are new for physicians and providers need help understanding what the program is, explained Mitzi Wasik,

Since providers see such different patient populations and operate in diverse settings, a one-size-fits-all P4P model is no longer the answer.

"Now we're in this new landscape where a patient has to get their bone mineral density test, what happens after that?" Ms Wasik asks. "What medicaiton are they put on? If they have a fall, what happens after the fall? And so we're looking at a more longitudinal type of pay for performance landscape that is now unfolding."

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
Miriam Freimer, MD
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo